{
    "clinical_study": {
        "@rank": "8062", 
        "arm_group": [
            {
                "arm_group_label": "Rifampicin", 
                "arm_group_type": "Active Comparator", 
                "description": "Rifampicin 600 mg daily"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo daily"
            }
        ], 
        "brief_summary": {
            "textblock": "We are investigating the effects of pregnane X receptor (PXR) activation on the regulation\n      of blood pressure in healthy volunteers. Rifampicin (an antibiotic and also an efficient PXR\n      activator) and placebo will be given for a week to volunteers and blood pressure is measured\n      24 hours using an ambulatory blood pressure monitor. Blood pressure regulating hormones will\n      be measured in blood. Our hypothesis is that PXR is involved in the regulation of blood\n      pressure."
        }, 
        "brief_title": "The Effect of PXR Activation on Blood Pressure Regulation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Blood Pressure Regulation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers\n\n          -  BMI 19-30 kg/m2\n\n          -  Age 18-40 years\n\n          -  Systolic blood pressure 95 - 140 mmHg\n\n        Exclusion Criteria:\n\n          -  Any continuous medication\n\n          -  Any significant medical condition as judged by the study physician\n\n          -  Diastolic blood pressure over 90 mmHg\n\n          -  Sensitivity to rifampicin\n\n          -  Pregnancy and lactation\n\n          -  Difficult venipuncture\n\n          -  Abuse of alcohol or medications, or drug use.\n\n          -  Participation in other trial with medications in previous 30 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690104", 
            "org_study_id": "Rifa-BP", 
            "secondary_id": "2011-005522-22"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rifampicin", 
                "intervention_name": "Rifampicin", 
                "intervention_type": "Drug", 
                "other_name": "Rimapen"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rifampin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "rifampicin", 
            "pregnane X receptor", 
            "blood pressure"
        ], 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "contact": {
                "email": "janne.hukkanen@oulu.fi", 
                "last_name": "Janne Hukkanen, MD, PhD", 
                "phone": "35883156212"
            }, 
            "facility": {
                "address": {
                    "city": "Oulu", 
                    "country": "Finland"
                }, 
                "name": "Oulu University Hospital"
            }, 
            "investigator": {
                "last_name": "Janne Hukkanen, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of PXR Activation on Blood Pressure Regulation", 
        "overall_contact": {
            "email": "janne.hukkanen@oulu.fi", 
            "last_name": "Janne Hukkanen, MD, PhD", 
            "phone": "35883156212"
        }, 
        "overall_official": {
            "affiliation": "Oulu University Hospital", 
            "last_name": "Janne Hukkanen, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Finland: Finnish Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Systolic blood pressure measured with ambulatory blood pressure monitor.", 
                "measure": "Systolic ambulatory blood pressure", 
                "safety_issue": "No", 
                "time_frame": "On day 8 of each arm"
            }, 
            {
                "description": "Diastolic blood pressure measured with ambulatory blood pressure monitor", 
                "measure": "Diastolic ambulatory blood pressure", 
                "safety_issue": "No", 
                "time_frame": "On day 8 of each arm"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690104"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Systolic and diastolic blood pressure", 
                "safety_issue": "No", 
                "time_frame": "On day 9 of each arm"
            }, 
            {
                "measure": "Pulse (ambulatory)", 
                "safety_issue": "No", 
                "time_frame": "On day 8 of each arm"
            }, 
            {
                "measure": "Plasma renin activity", 
                "safety_issue": "No", 
                "time_frame": "On day 9 of each arm"
            }, 
            {
                "measure": "Serum aldosterone", 
                "safety_issue": "No", 
                "time_frame": "On day 9 of each arm"
            }
        ], 
        "source": "University of Oulu", 
        "sponsors": {
            "collaborator": {
                "agency": "Oulu University Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Oulu", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}